[go: up one dir, main page]

UY27686A1 - NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. - Google Patents

NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.

Info

Publication number
UY27686A1
UY27686A1 UY27686A UY27686A UY27686A1 UY 27686 A1 UY27686 A1 UY 27686A1 UY 27686 A UY27686 A UY 27686A UY 27686 A UY27686 A UY 27686A UY 27686 A1 UY27686 A1 UY 27686A1
Authority
UY
Uruguay
Prior art keywords
preparation
medications
procedures
new salts
cinamic acid
Prior art date
Application number
UY27686A
Other languages
Spanish (es)
Inventor
Rainer Soyka
Gunter Linz
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002109243 external-priority patent/DE10209243A1/en
Priority claimed from DE2002116124 external-priority patent/DE10216124A1/en
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27686A1 publication Critical patent/UY27686A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

El presente invento concierne a nuevas composiciones de medicamento sobre la basee de sales de tiotropio y sales del salmeterol, procedimientos para su preparación, asi como su utilización en la terapia de las enfermedades de vias respiratorias.The present invention concerns new medicament compositions based on tiotropium salts and salmeterol salts, methods for their preparation, as well as their use in the therapy of respiratory tract diseases.

UY27686A 2002-03-04 2003-02-27 NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS. UY27686A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002109243 DE10209243A1 (en) 2002-03-04 2002-03-04 Synergistic, well tolerated medicament combination of tiotropium salt and sparingly water-soluble salmeterol salt, useful for treating asthma or chronic obstructive pulmonary disease
DE2002116124 DE10216124A1 (en) 2002-04-12 2002-04-12 New cinnamic acid salts of salmeterol useful for the treatment of e.g. chronic obstructive pulmonary disease

Publications (1)

Publication Number Publication Date
UY27686A1 true UY27686A1 (en) 2003-10-31

Family

ID=27789722

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27686A UY27686A1 (en) 2002-03-04 2003-02-27 NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.

Country Status (9)

Country Link
EP (1) EP1483231A1 (en)
JP (1) JP2005519110A (en)
AR (1) AR038622A1 (en)
AU (1) AU2003221482A1 (en)
CA (1) CA2477714C (en)
PE (1) PE20030933A1 (en)
TW (1) TW200404759A (en)
UY (1) UY27686A1 (en)
WO (1) WO2003074469A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2265276B1 (en) * 2005-05-20 2008-02-01 Laboratorios Almirall S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) Phenol as agonists of the BETA2 ADRENERGIC RECEIVER.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310477D0 (en) * 1983-04-18 1983-05-25 Glaxo Group Ltd Chemical compounds
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4791108A (en) * 1987-04-13 1988-12-13 Syntex (U.S.A.) Inc. Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Pharmaceutical compositions comprising salmeterol and fluticasone propionate
RU2081108C1 (en) * 1991-10-16 1997-06-10 Циба-Гейги АГ Additive salts of acids with the base and pharmaceutical composition showing antitumor activity

Also Published As

Publication number Publication date
WO2003074469A1 (en) 2003-09-12
EP1483231A1 (en) 2004-12-08
AR038622A1 (en) 2005-01-19
CA2477714C (en) 2011-01-25
JP2005519110A (en) 2005-06-30
AU2003221482A1 (en) 2003-09-16
TW200404759A (en) 2004-04-01
CA2477714A1 (en) 2003-09-12
PE20030933A1 (en) 2003-12-15

Similar Documents

Publication Publication Date Title
ECSP034571A (en) NEW COMPOSITIONS OF MEDICINES BASED ON SALOTETOL SALTS AND TIOTROPIO SALTS
AR034213A1 (en) COMPOSITIONS OF DRUGS ON THE BASE OF ANTI-POLINERGIC AGENTS AND INHIBITORS OF PDE-IV
UY26992A1 (en) NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTICHOLINERGIC AND CORTICOESTEROID AGENTS
UY34358A (en) ? TREATMENT OF MULTIPLE SCLEROSIS WITH A COMBINATION OF LAQUINIMOD AND ACETATO DE GLATIRAMER ?.
UA98136C2 (en) Use of aclidinium for the treatment of respiratory diseases
UY27759A1 (en) COMBINATIONS OF DRUGS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTI-POLYNERGIC AGENT.
UY28757A1 (en) SUBSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
CY1106430T1 (en) MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG
ECSP066734A (en) ACID DERIVATIVES 7-PHENYLAMINE-4-QUINOLONA-3-CARBOXYL, METHODS FOR PRODUCTION AND USE AS MEDICATIONS
UA110463C2 (en) PHARMACEUTICAL COMPOSITION OF 4-{[9-CHLORO-7-(2-FLUORO-6-METHOXYPHENYL)-5H-PYRIMIDO[5,4-d][2]BENZAZIPINE-2-YL]AMINO}-2-METHOXT BENZOIC ACID FOR TREATMENT OF CANCER AND OTHER DISEASES AND IMPAIRED HEALTH CONDITIONS
IL164291A0 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
CL2008001820A1 (en) Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
UY27758A1 (en) MEDICINAL CONTAINING STEROIDS AND A NEW ANTI-POLYNERGIC
ECSP066545A (en) PROCEDURE FOR THE PREPARATION OF TIOTROPIO SALTS, TIOTROPAL SALTS, AS WELL AS MEDICINAL FORMULATIONS CONTAINING THEM
ECSP077843A (en) PRURITE TREATMENT OR PREVENTION
UY28590A1 (en) PROCEDURE FOR THE PREPARATION OF NEW SALTS OF TIOTROPIO, NEW SALTS OF TIOTROPIO AS SUCH, AS WELL AS THE MEDICINAL FORMULATIONS CONTAINING THEM.
BRPI0519351A2 (en) medicines for the treatment or prevention of fibrotic diseases
UY27670A1 (en) NEW COMPOSITIONS OF MEDICINES ON THE BASE OF ANTI-POLYNERGIC AGENTS AND INHIBITING AGENTS OF THE EGFR KINASE
AR079000A1 (en) ANTI-BANK THERAPY AIMED AT CANCEROSA MOTHER RESISTANT DRUG CELLS
UY27445A1 (en) NEW MEDICINES FOR INHALATION.
EA200700484A1 (en) PHARMACEUTICAL COMPOSITION OF TLTERODIN WITH PROLONGED DELIVERY
UY27686A1 (en) NEW SALTS OF CINAMIC ACID, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
BR0312507A (en) Drug compositions based on novel anticholinergics and egfr kinase inhibitors
UY28096A1 (en) NEW PULVEURLENT FORMULATION CONTAINING INHALATION TIOTROPY
ECSP045357A (en) MEDICINAL CONTAINING BETAMIMETICS AND A NEW ANTI-POLERIGEN

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126